SUMMARY OF THE STUDY
The study was done in Switzerland. A total of 185 patients who were over 65 years old with an elevated TSH level and normal free T4 levels were studied. Patients were given either levothyroxine (thyroid hormone) or placebo (a pill without a medication). A total of 96 patients with TSH levels above 4.6 mIU/L received levothyroxine; only 4 of these patients had a TSH level above 10 mIU/L. A total of 89 patients were in the placebo group. The levothyroxine starting dose was 25 mcg or 50 mcg. The dose was increased slowly until the TSH was normal. The researchers evaluated the heart muscle function, strength, and stiffness using echocardiography at the end of the study.
After 18 months of treatment TSH levels decreased into normal range with levothyroxine and remained elevated around 5.29 mIU/L with placebo. There was no difference in ejection fraction (how well the heart pumps blood with each beat) or in the measures of stiffness (how well the heart relaxes between beats) between the 2 groups.
WHAT ARE THE IMPLICATIONS OF THIS STUDY?
Thyroid hormone treatment did not have any effect on heart function in patients with mild/subclinical hypothyroidism who were over 65 years old. This is the largest study assessing the effects of thyroid hormone treatment on heart function in this age group. Based on the results of this study, treatment of patients over 65 years old with very mild TSH elevation, especially if less than 10 mIU/L, can be avoided. This approach would mean one less medication to take and it would protect these patients from the risks of taking thyroid hormone.
— Ebru Sulanc, MD